Your browser doesn't support javascript.
loading
Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward.
Reeves, Kaitlin C; Kube, Megan J; Grecco, Gregory G; Fritz, Brandon M; Muñoz, Braulio; Yin, Fuqin; Gao, Yong; Haggerty, David L; Hoffman, Hunter J; Atwood, Brady K.
Afiliação
  • Reeves KC; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Kube MJ; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Grecco GG; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Fritz BM; Medical Scientist Training Program, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Muñoz B; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Yin F; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Gao Y; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Haggerty DL; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Hoffman HJ; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Atwood BK; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Addict Biol ; 26(3): e12942, 2021 05.
Article em En | MEDLINE | ID: mdl-32686251
ABSTRACT
The role of Mu opioid receptor (MOR)-mediated regulation of GABA transmission in opioid reward is well established. Much less is known about MOR-mediated regulation of glutamate transmission in the brain and how this relates to drug reward. We previously found that MORs inhibit glutamate transmission at synapses that express the Type 2 vesicular glutamate transporter (vGluT2). We created a transgenic mouse that lacks MORs in vGluT2-expressing neurons (MORflox-vGluT2cre) to demonstrate that MORs on the vGluT2 neurons themselves mediate this synaptic inhibition. We then explored the role of MORs in vGluT2-expressing neurons in opioid-related behaviors. In tests of conditioned place preference, MORflox-vGluT2cre mice did not acquire place preference for a low dose of the opioid, oxycodone, but displayed conditioned place aversion at a higher dose, whereas control mice displayed preference for both doses. In an oral consumption assessment, these mice consumed less oxycodone and had reduced preference for oxycodone compared with controls. MORflox-vGluT2cre mice also failed to show oxycodone-induced locomotor stimulation. These mice displayed baseline withdrawal-like responses following the development of oxycodone dependence that were not seen in littermate controls. In addition, withdrawal-like responses in these mice did not increase following treatment with the opioid antagonist, naloxone. However, other MOR-mediated behaviors were unaffected, including oxycodone-induced analgesia. These data reveal that MOR-mediated regulation of glutamate transmission is a critical component of opioid reward.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxicodona / Receptores Opioides mu / Proteína Vesicular 2 de Transporte de Glutamato / Neurônios Limite: Animals Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxicodona / Receptores Opioides mu / Proteína Vesicular 2 de Transporte de Glutamato / Neurônios Limite: Animals Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos